Time-dependent release of growth factors from implant surfaces treated with plasma rich in growth factors

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 5, 2013, Pages 1478-1488

  Sánchez Ilárduya, María Belén ^a   Trouche, Elodie ^a,b   Tejero, Ricardo ^a,b,c   Orive, Gorka ^b,c,d   Reviakine, Ilya ^a,c   Anitua, Eduardo ^b,e  

^a CIC BIOMAGUNE   (Spain)

^b BTI I+D   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^e Private Practice in Implantology and Oral Rehabilitation   (Spain)

Author keywords

activation; calcium; growth factors; platelet rich plasma; PRGF Endoret; thrombin

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RELEASE; HEPATOCYTE GROWTH FACTOR; PLASMA RICH IN GROWTH FACTORS; PLATELET RICH PLASMA; PLATELET-DERIVED GROWTH FACTORS; PRGF-ENDORET; THROMBIN;

CALCIUM; CHEMICAL ACTIVATION; DENTAL PROSTHESES; PLASMA (HUMAN); PLATELETS; TISSUE REGENERATION;

PLASMAS;

FIBRIN; PLASMA RICH IN GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; BLOOD CLOTTING; BONE REGENERATION; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; IMPLANT; MORPHOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION;

FIBRIN; HEPATOCYTE GROWTH FACTOR; HUMANS; PLASMA; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; PROSTHESES AND IMPLANTS;

EID: 84884211338     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34428     Document Type: Article

References (77)

1. Vermylen J,. Role of platelet activation and fibrin formation in thrombogenesis. J Am Coll Cardiol 1986; 8: 2-9.
2. Eyre L, Gamlin F,. Haemostasis, blood platelets and coagulation. Anaesth Intensive Care Med 2010; 11: 244-246.
3. Furie B, Furie BC,. The molecular basis of blood coagulation. Cell 1988; 53: 505-518.
4. Michelson A,. Platelets. London: Academic Press; 2007.
5. Minors D,. Haemostasis, blood platelets and coagulation. Anaesth Intensive Care Med 2007; 8: 214-216.
6. Leslie M,. Beyond clotting: The powers of platelets. Science 2010; 328: 562-564.
7. Eppley BL, Pietrzak WS, Blanton M,. Platelet-rich plasma: A review of biology and applications in plastic surgery. Plast Reconstr Surg 2006; 118: 147E-159E.
8. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT,. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91: 4-15.
9. De Biase P, Campanacci DA, Beltrami G, Scoccianti G, Ciampalini L, Pecchioli O, Capanna R,. Scaffolds combined with stem cells and growth factors in healing of pseudotumoral lesions of bone. Int J Immunopathol Pharmacol 2011; 24: 11-15.
10. Judith R, Nithya M, Rose C, Mandal AB,. Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci 2010; 87: 1-8.
11. Ksander GA, Chu GH, McMullin H, Ogawa Y, Pratt BM, Rosenblatt JS, McPherson JM,. Transforming growth factors-beta 1 and beta 2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent. Ann N Y Acad Sci 1990; 593: 135-147.
12. Palu A, Su C, Zhou B-N, West B, Jensen J,. Wound healing effects of noni (Morinda citrifolia L.) leaves: A mechanism involving its PDGF/A2A receptor ligand binding and promotion of wound closure. Phytother Res 2010; 24: 1437-1441.
13. Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM, Thomason A,. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol 1992; 140: 1375-1388.
14. Hu X, Neoh KG, Shi Z, Kang ET, Poh C, Wang W,. An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion. Biomaterials 2010; 31: 8854-8863.
15. Ramazanoglu M, Lutz R, Ergun C, von Wilmowsky C, Nkenke E, Schlegel KA,. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration. Clin Oral Implants Res 2011; 22: 1433-1439.
16. Hayashi K, Kubo T, Doi K, Tabata Y, Akagawa Y,. Development of new drug delivery system for implant bone augmentation using a basic fibroblast growth factor-gelatin hydrogel complex. Dent Mater J 2007; 26: 170-177.
17. Luginbuehl V, Meinel L, Merkle HP, Gander B,. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004; 58: 197-208.
18. Luo T, Zhang W, Shi B, Cheng X, Zhang Y,. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. Clin Oral Implants Res 2011.
19. Porter JR, Ruckh TT, Popat KC,. Bone tissue engineering: A review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009; 25: 1539-1560.
20. Putney SD, Burke PA,. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol 1998; 16: 153-157.
21. Anitua E, SÃinchez M, Orive G, Andia I,. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008; 29: 37-41.
22. Whitman DH, Berry RL, Green DM,. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55: 1294-1299.
23. Anitua E,. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999; 14: 529-535.
24. Fréchette JP, Martineau I, Gagnon G,. Platelet-rich plasmas: Growth factor content and roles in wound healing. J Dent Res 2005; 84: 434-439.
25. Kevy SV, Jacobson MS,. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 2004; 36: 28-35.
26. Marlovits S, Mousavi M, Gäbler C, Erdös J, Vécsei V,. A new simplified technique for producing platelet-rich plasma: a short technical note. Eur Spine J 2004; 13: S102-S106.
27. Weibrich G, Kleis WKG, Hafner G, Hitzler WE,. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002; 30: 97-102.
28. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE,. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004; 34: 665-671.
29. Anitua E,. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007; 28: 4551-4560.
30. Anitua E, Orive G, Pla R, Roman P, Serrano V, Andia I,. The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: A histologic and histomorphometric study. J Biomed Mater Res A 2009; 91: 158-165.
31. Anitua EA,. Enhancement of osseointegration by generating a dynamic implant surface. J Oral Implantol 2006; 32: 72-76.
32. Anitua E, Sánchez M, Prado R, Orive G,. Plasma rich in growth factors: The pioneering autologous technology for tissue regeneration. J Biomed Mater Res A 2011; 97: 536.
33. Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I,. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 2006; 24: 227-234.
34. Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I,. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res Part A 2006; 77A: 285-293.
35. Anitua E, Sanchez M, Orive G,. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 2010; 62: 741-752.
36. Anitua E, Sanchez M, Orive G, Andia I,. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007; 28: 4551-4560.
37. Lieberman JR, Daluiski A, Einhorn TA,. The role of growth factors in the repair of bone biology and clinical applications. J Bone Joint Surg Am 2002; 84: 1032-1044.
38. Sanchez M, Anitua E, Orive G, Mujika I, Andia I,. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009; 39: 345-354.
39. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR,. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-646.
40. Broughton G, 2nd, Janis JE, Attinger CE,. The basic science of wound healing. Plast Reconstr Surg 2006; 117: 12S-34S.
41. Ryan EA, Mockros LF, Weisel JW, Lorand L,. Structural origins of fibrin clot rheology. Biophys J 1999; 77: 2813-2826.
42. Weisel JW, Nagaswami C,. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: Clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-128.
43. Borrelli V, Sterpetti AV, Coluccia P, Randone B, Cavallaro A, Santoro D'Angelo L, Cucina A,. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. J Surg Res 2001; 100: 154-160.
44. Vesely D, Astl J, Lastuvka P, Matucha P, Sterzl I, Betka J,. Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors. Physiol Res 2004; 53: 83-89.
45. Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y,. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer 2002; 95: 824-834.
46. Bowen-Pope DF, Malpass TW, Foster DM, Ross R,. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood 1984; 64: 458-469.
47. Selimovic N, Bergh CH, Andersson B, Sakiniene E, Carlsten H, Rundqvist B,. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension. Eur Respir J 2009; 34: 662-668.
48. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, Peters A,. Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 2006; 290: E434-E439.
49. Tajima H,. Hepatscyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett 1991; 291: 229-232.
50. Nakamura T,. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
51. Ohmichi H,. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development 1998; 125: 1315-1324.
52. Rhen T, Jangula A, Schroeder A, Woodward-Bosh R,. The platelet-derived growth factor signaling system in snapping turtle embryos, Chelydra serpentina: Potential role in temperature-dependent sex determination and testis development. Gen Comp Endocrinol 2009; 161: 335-343.
53. Kurth P, Moenning A, Jager R, Beine G, Schorle H,. An activating mutation in the PDGF receptor alpha results in embryonic lethality caused by malformation of the vascular system. Dev Dyn 2009; 238: 1064-1072.
54. Keerl S, Gehmert S, Gehmert S, Song YH, Alt E,. PDGF and bFGF modulate tube formation in adipose tissue-derived stem cells. Ann Plast Surg 2010; 64: 487-490.
55. Wiens KM, Lee HL, Shimada H, Metcalf AE, Chao MY, Lien CL,. Platelet-derived growth factor receptor beta is critical for zebrafish intersegmental vessel formation. PLoS One 2010; 5: e11324.
56. Graves DT, Valentin-Opran A, Delgado R, Valente AJ, Mundy G, Piche J,. The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells. Connect Tissue Res 1989; 23: 209-218.
57. Abouantoun TJ, Castellino RC, Macdonald TJ,. Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells. J Neurooncol 2011.
58. Chen CP, Hung CF, Lee SC, Lo HM, Wu PH, Wu WB,. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: Prediction of the possible lycopene binding site within PDGF. Naunyn Schmiedebergs Arch Pharmacol 2010; 381: 401-414.
59. Moenning A, Jager R, Egert A, Kress W, Wardelmann E, Schorle H,. Sustained platelet-derived growth factor receptor alpha signaling in osteoblasts results in craniosynostosis by overactivating the phospholipase C-gamma pathway. Mol Cell Biol 2009; 29: 881-891.
60. Visnapuu V, Peltomaki T, Ronning O, Vahlberg T, Helenius H,. Distribution of fibroblast growth factors (FGFR-1 and -3) and platelet-derived growth factor receptors (PDGFR) in the rat mandibular condyle during growth. Orthod Craniofac Res 2002; 5: 147-153.
61. Xu X, Bringas P Jr, Soriano P, Chai Y,. PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis. Dev Dyn 2005; 232: 75-84.
62. Lebman DA, Edmiston JS,. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1999; 1: 1297-1304.
63. Letterio JJ, Roberts AB,. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137-161.
64. Beanes SR, Dang C, Soo C, Ting K,. Skin repair and scar formation: the central role of TGF-beta. Expert Rev Mol Med 2003; 5: 1-22.
65. Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de Crombrugghe B, Davidson JM, Bhowmick NA,. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 2010; 176: 98-107.
66. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W,. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629-17634.
67. Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA,. Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res 2008; 68: 4340-4346.
68. Makinde T, Murphy RF, Agrawal DK,. Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling. Curr Mol Med 2006; 6: 831-841.
69. Mitola S, Sozzani S, Luini W, Primo L, Borsatti A, Weich H, Bussolino F,. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997; 90: 1365-1372.
70. Nogami M, Hoshi T, Kinoshita M, Arai T, Takama M, Takahashi I,. Vascular endothelial growth factor expression in rat skin incision wound. Med Mol Morphol 2007; 40: 82-87.
71. Ferrara N,. VEGF-A: A critical regulator of blood vessel growth. Eur Cytokine Netw 2009; 20: 158-163.
72. Appelmann I, Liersch R, Kessler T, Mesters RM, Berdel WE,. Angiogenesis inhibition in cancer therapy: Platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: Biological functions and role in malignancy. Recent Results Cancer Res 2010; 180: 51-81.
73. Han YF, Han YQ, Pan YG, Chen YL, Chai JK,. Transplantation of microencapsulated cells expressing VEGF improves angiogenesis in implanted xenogeneic acellular dermis on wound. Transplant Proc 2010; 42: 1935-1943.
74. 2+/calcineurin and protein kinase C-delta. PLoS One 2010; 5: e11435.
75. Myshin HL, Wiens JP,. Factors affecting soft tissue around dental implants: A review of the literature. J Prosthet Dent 2005; 94: 440-444.
76. Palmquist A, Omar OM, Esposito M, Lausmaa J, Thomsen P,. Titanium oral implants: surface characteristics, interface biology and clinical outcome. J R Soc Interface 2010; 7: S515-S527.
77. Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, Desiderio MA,. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF. J Cell Physiol 2010; 225: 757-766.